These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6296567)

  • 41. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites.
    Nijssen PC; Sexton T; Childers SR
    J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of opiates on cAMP in homogenates and slices of rat striata.
    Havemann U; Kuschinsky K
    Pharmacology; 1978; 16(5):295-9. PubMed ID: 205887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of adenylate cyclase by GTP and its modulation by opiate receptor in rat caudate nucleus.
    Kamikubo K; Nozaki M; Fujimura H
    Jpn J Pharmacol; 1981 Apr; 31(2):175-84. PubMed ID: 6273623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.
    Valentino RJ; Katz JL; Medzihradsky F; Woods JH
    Life Sci; 1983 Jun; 32(25):2887-96. PubMed ID: 6304445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis.
    Makman MH; Bilfinger TV; Stefano GB
    J Immunol; 1995 Feb; 154(3):1323-30. PubMed ID: 7822801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bimodal opioid regulation of cyclic AMP formation: implications for positive and negative coupling of opiate receptors to adenylyl cyclase.
    Wang L; Gintzler AR
    J Neurochem; 1994 Nov; 63(5):1726-30. PubMed ID: 7931327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
    Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C
    Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase.
    Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG
    Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opiate-inhibited adenylate cyclase in rat brain membranes depleted of Gs-stimulated adenylate cyclase.
    Childers SR
    J Neurochem; 1988 Feb; 50(2):543-53. PubMed ID: 2826699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of adenylate cyclase in presynaptic alpha 2-adrenoceptor- and mu-opioid receptor-mediated inhibition of [3H]noradrenaline release from rat brain cortex slices.
    Schoffelmeer AN; Wierenga EA; Mulder AH
    J Neurochem; 1986 Jun; 46(6):1711-7. PubMed ID: 2422322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calmodulin increases in selective brain regions with opioid dependence.
    Bonnet KA; Engelberg L; Gusik SA
    Life Sci; 1982 Nov 15-22; 31(20-21):2295-8. PubMed ID: 6298523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
    Schoffelmeer AN; De Vries TJ; Hogenboom F; Hruby VJ; Portoghese PS; Mulder AH
    J Pharmacol Exp Ther; 1992 Oct; 263(1):20-4. PubMed ID: 1328606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Sep; 226(3):770-5. PubMed ID: 6310081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of dopamine-stimulated cyclic AMP efflux from rat neostriatal slices by activation of mu- and delta-opioid receptors: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
    Eur J Pharmacol; 1985 Dec; 118(3):363-6. PubMed ID: 2417870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Photoaffinity labeling of opiate receptors using intrinsically photoactive 3H-opiates.
    Kooper GN; Levinson NR; Copeland CF; Bowen WD
    Mol Pharmacol; 1988 Mar; 33(3):316-26. PubMed ID: 2832721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneity of opioid receptor binding in brain slices.
    Barchfeld-Rothschild CC; Medzihradsky F
    J Neurosci Res; 1987; 18(2):358-65. PubMed ID: 2891857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.